West Pharmaceutical Services, Inc.
WST
$263.51
-$15.59-5.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 131.80M | 89.80M | 130.10M | 136.00M | 111.30M |
| Total Depreciation and Amortization | 41.40M | 40.00M | 40.70M | 40.20M | 38.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.00M | -500.00K | -4.20M | 4.00M | 700.00K |
| Change in Net Operating Assets | -4.10M | 100.00K | 23.50M | -100.00K | 14.10M |
| Cash from Operations | 177.10M | 129.40M | 190.10M | 180.10M | 165.00M |
| Capital Expenditure | -75.20M | -71.30M | -104.90M | -81.30M | -100.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00K | -800.00K | -1.00M |
| Cash from Investing | -75.20M | -71.30M | -104.80M | -82.10M | -101.20M |
| Total Debt Issued | -- | -- | 0.00 | 129.70M | 35.00M |
| Total Debt Repaid | -300.00K | -200.00K | -100.00K | -133.20M | -58.30M |
| Issuance of Common Stock | 5.20M | 4.40M | 3.10M | 6.00M | 6.80M |
| Repurchase of Common Stock | -500.00K | -136.00M | -54.60M | -52.40M | -187.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.10M | -15.20M | -15.30M | -14.50M | -14.60M |
| Other Financing Activities | -4.20M | -- | -2.00M | -- | -- |
| Cash from Financing | -14.90M | -147.00M | -68.90M | -64.40M | -218.30M |
| Foreign Exchange rate Adjustments | 18.50M | 8.50M | -22.70M | 11.10M | -1.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.50M | -80.40M | -6.30M | 44.70M | -155.60M |